Federation des caisses Desjardins du Quebec’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,500
| Closed | -$27.3K | – | 2655 |
|
2024
Q2 | $27.3K | Hold |
1,500
| – | – | ﹤0.01% | 1533 |
|
2024
Q1 | $27.4K | Hold |
1,500
| – | – | ﹤0.01% | 1560 |
|
2023
Q4 | $29.2K | Hold |
1,500
| – | – | ﹤0.01% | 1473 |
|
2023
Q3 | $26.6K | Hold |
1,500
| – | – | ﹤0.01% | 1491 |
|
2023
Q2 | $30.7K | Hold |
1,500
| – | – | ﹤0.01% | 1470 |
|
2023
Q1 | $30.4K | Hold |
1,500
| – | – | ﹤0.01% | 1460 |
|
2022
Q4 | $33.4K | Hold |
1,500
| – | – | ﹤0.01% | 1561 |
|
2022
Q3 | $30.8K | Hold |
1,500
| – | – | ﹤0.01% | 1635 |
|
2022
Q2 | $34.6K | Hold |
1,500
| – | – | ﹤0.01% | 1615 |
|
2022
Q1 | $40.5K | Hold |
1,500
| – | – | ﹤0.01% | 1643 |
|
2021
Q4 | $52.9K | Hold |
1,500
| – | – | ﹤0.01% | 1580 |
|
2021
Q3 | $60.8K | Hold |
1,500
| – | – | ﹤0.01% | 1546 |
|
2021
Q2 | $59.4K | Hold |
1,500
| – | – | ﹤0.01% | 1553 |
|
2021
Q1 | $52.6K | Hold |
1,500
| – | – | ﹤0.01% | 1535 |
|
2020
Q4 | $43.2K | Buy |
1,500
+1,370
| +1,054% | +$39.4K | ﹤0.01% | 1532 |
|
2020
Q3 | $3.56K | Buy |
+130
| New | +$3.56K | ﹤0.01% | 1931 |
|